Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Jason Glanz to Immunization Schedule

This is a "connection" page, showing publications Jason Glanz has written about Immunization Schedule.

 
Connection Strength
  
 
 
5.568
  
  1. Glanz JM, Clarke CL, Daley MF, Shoup JA, Hambidge SJ, Williams JTB, Groom HC, Kharbanda EO, Klein NP, Jackson LA, Lewin BJ, McClure DL, Xu S, DeStefano F. The Childhood Vaccination Schedule and the Lack of Association With Type 1 Diabetes. Pediatrics. 2021 12 01; 148(6).
    View in: PubMed
    Score: 0.651
  2. Dempsey AF, Wagner N, Narwaney K, Pyrzanowski J, Kwan BM, Kraus C, Gleason K, Resnicow K, Sevick C, Cataldi J, Brewer SE, Glanz JM. 'Reducing Delays In Vaccination' (REDIVAC) trial: a protocol for a randomised controlled trial of a web-based, individually tailored, educational intervention to improve timeliness of infant vaccination. BMJ Open. 2019 05 22; 9(5):e027968.
    View in: PubMed
    Score: 0.547
  3. Xu S, Newcomer SR, Kulldorff M, Daley MF, Fireman B, Glanz JM. Use of three summary measures of pediatric vaccination for studying the safety of the childhood immunization schedule. Vaccine. 2019 02 28; 37(10):1325-1331.
    View in: PubMed
    Score: 0.535
  4. Daley MF, Shoup JA, Newcomer SR, Jackson ML, Groom HC, Jacobsen SJ, McLean HQ, Klein NP, Weintraub ES, McNeil MM, Glanz JM. Assessing Potential Confounding and Misclassification Bias When Studying the Safety of the Childhood Immunization Schedule. Acad Pediatr. 2018 Sep - Oct; 18(7):754-762.
    View in: PubMed
    Score: 0.505
  5. Glanz JM, Newcomer SR, Daley MF, DeStefano F, Groom HC, Jackson ML, Lewin BJ, McCarthy NL, McClure DL, Narwaney KJ, Nordin JD, Zerbo O. Association Between Estimated Cumulative Vaccine Antigen Exposure Through the First 23 Months of Life and Non-Vaccine-Targeted Infections From 24 Through 47 Months of Age. JAMA. 2018 03 06; 319(9):906-913.
    View in: PubMed
    Score: 0.503
  6. Newcomer SR, Kulldorff M, Xu S, Daley MF, Fireman B, Lewis E, Glanz JM. Bias from outcome misclassification in immunization schedule safety research. Pharmacoepidemiol Drug Saf. 2018 02; 27(2):221-228.
    View in: PubMed
    Score: 0.497
  7. Glanz JM, Newcomer SR, Jackson ML, Omer SB, Bednarczyk RA, Shoup JA, DeStefano F, Daley MF. White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink. Vaccine. 2016 Feb 15; 34 Suppl 1:A1-A29.
    View in: PubMed
    Score: 0.436
  8. Glanz JM, Newcomer SR, Narwaney KJ, Hambidge SJ, Daley MF, Wagner NM, McClure DL, Xu S, Rowhani-Rahbar A, Lee GM, Nelson JC, Donahue JG, Naleway AL, Nordin JD, Lugg MM, Weintraub ES. A population-based cohort study of undervaccination in 8 managed care organizations across the United States. JAMA Pediatr. 2013 Mar 01; 167(3):274-81.
    View in: PubMed
    Score: 0.355
  9. Albers AN, Fox ER, Michels SY, Daley MF, Glanz JM, Newcomer SR. Late initiation of pneumococcal and Haemophilus influenzae type b vaccinations. Vaccine. 2025 Aug 30; 62:127611.
    View in: PubMed
    Score: 0.211
  10. Albers AN, Michels SY, Daley MF, Glanz JM, Newcomer SR. Invalid Vaccine Doses Among Children Aged 0 to 35 Months: 2011 to 2020. Pediatrics. 2025 Feb 01; 155(2).
    View in: PubMed
    Score: 0.203
  11. Wang SV, Stefanini K, Lewis E, Newcomer SR, Fireman B, Daley MF, Glanz JM, Duffy J, Weintraub E, Kulldorff M. Determining Which of Several Simultaneously Administered Vaccines Increase Risk of an Adverse Event. Drug Saf. 2020 10; 43(10):1057-1065.
    View in: PubMed
    Score: 0.150
  12. Newcomer SR, Daley MF, Narwaney KJ, Xu S, DeStefano F, Groom HC, Jackson ML, Lewin BJ, McLean HQ, Nordin JD, Zerbo O, Glanz JM. Order of Live and Inactivated Vaccines and Risk of Non-vaccine-targeted Infections in US Children 11-23 Months of Age. Pediatr Infect Dis J. 2020 03; 39(3):247-253.
    View in: PubMed
    Score: 0.144
  13. Jackson ML, Yu O, Nelson JC, Nordin JD, Tartof SY, Klein NP, Donahue JG, Irving SA, Glanz JM, McNeil MM, Jackson LA. Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents. Pharmacoepidemiol Drug Saf. 2018 08; 27(8):921-925.
    View in: PubMed
    Score: 0.128
  14. Wang SV, Abdurrob A, Spoendlin J, Lewis E, Newcomer SR, Fireman B, Daley MF, Glanz JM, Duffy J, Weintraub ES, Kulldorff M. Methods for addressing "innocent bystanders" when evaluating safety of concomitant vaccines. Pharmacoepidemiol Drug Saf. 2018 04; 27(4):405-412.
    View in: PubMed
    Score: 0.125
  15. McCarthy NL, Sukumaran L, Newcomer S, Glanz J, Daley MF, McClure D, Klein NP, Irving S, Jackson ML, Lewin B, Weintraub E. Patterns of childhood immunization and all-cause mortality. Vaccine. 2017 12 04; 35(48 Pt B):6643-6648.
    View in: PubMed
    Score: 0.122
  16. Daley MF, Glanz JM, Newcomer SR, Jackson ML, Groom HC, Lugg MM, McLean HQ, Klein NP, Weintraub ES, McNeil MM. Assessing misclassification of vaccination status: Implications for studies of the safety of the childhood immunization schedule. Vaccine. 2017 04 04; 35(15):1873-1878.
    View in: PubMed
    Score: 0.117
  17. Hambidge SJ, Newcomer SR, Narwaney KJ, Glanz JM, Daley MF, Xu S, Shoup JA, Rowhani-Rahbar A, Klein NP, Lee GM, Nelson JC, Lugg M, Naleway AL, Nordin JD, Weintraub E, DeStefano F. Timely versus delayed early childhood vaccination and seizures. Pediatrics. 2014 Jun; 133(6):e1492-9.
    View in: PubMed
    Score: 0.097
  18. Glanz JM, Narwaney KJ, Newcomer SR, Daley MF, Hambidge SJ, Rowhani-Rahbar A, Lee GM, Nelson JC, Naleway AL, Nordin JD, Lugg MM, Weintraub ES. Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age. JAMA Pediatr. 2013 Nov; 167(11):1060-4.
    View in: PubMed
    Score: 0.093
  19. Daley MF, Clarke CL, Glanz JM, Albers AN, Michels SY, Freeman RE, Newcomer SR. National trends in patterns of under-vaccination in early childhood: National Immunization Survey-Child, United States, 2011-2021. Expert Rev Vaccines. 2024 Jan-Dec; 23(1):740-749.
    View in: PubMed
    Score: 0.049
  20. Newcomer SR, Glanz JM, Daley MF. Beyond Vaccination Coverage: Population-Based Measurement of Early Childhood Immunization Schedule Adherence. Acad Pediatr. 2023 Jan-Feb; 23(1):24-34.
    View in: PubMed
    Score: 0.043
  21. Freeman RE, Thaker J, Daley MF, Glanz JM, Newcomer SR. Vaccine timeliness and prevalence of undervaccination patterns in children ages 0-19 months, U.S., National Immunization Survey-Child 2017. Vaccine. 2022 01 31; 40(5):765-773.
    View in: PubMed
    Score: 0.041
  22. France EK, Glanz J, Xu S, Hambidge S, Yamasaki K, Black SB, Marcy M, Mullooly JP, Jackson LA, Nordin J, Belongia EA, Hohman K, Chen RT, Davis R. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics. 2008 Mar; 121(3):e687-92.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)